[go: up one dir, main page]

AR033596A1 - Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno - Google Patents

Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno

Info

Publication number
AR033596A1
AR033596A1 ARP010105804A ARP010105804A AR033596A1 AR 033596 A1 AR033596 A1 AR 033596A1 AR P010105804 A ARP010105804 A AR P010105804A AR P010105804 A ARP010105804 A AR P010105804A AR 033596 A1 AR033596 A1 AR 033596A1
Authority
AR
Argentina
Prior art keywords
intramuscular injection
loxoprophene
pharmaceutical composition
injection containing
formulation
Prior art date
Application number
ARP010105804A
Other languages
English (en)
Original Assignee
Shin Poong Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co filed Critical Shin Poong Pharmaceutical Co
Publication of AR033596A1 publication Critical patent/AR033596A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una formulacion para inyeccion intramuscular, la cual contiene loxoprofeno o una sal farmacéuticamente aceptable del mismo, que presenta un excelente efecto analgésico antiinflamatorio, como ingrediente activo
ARP010105804A 2000-12-14 2001-12-14 Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno AR033596A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0076298A KR100405161B1 (ko) 2000-12-14 2000-12-14 록소프로펜 함유 근육주사제 조성물

Publications (1)

Publication Number Publication Date
AR033596A1 true AR033596A1 (es) 2003-12-26

Family

ID=36691545

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105804A AR033596A1 (es) 2000-12-14 2001-12-14 Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno

Country Status (12)

Country Link
JP (1) JP2004515526A (es)
KR (1) KR100405161B1 (es)
CN (1) CN1278672C (es)
AP (1) AP1530A (es)
AR (1) AR033596A1 (es)
AU (1) AU2002222750A1 (es)
BR (1) BR0108313A (es)
MX (1) MXPA02007788A (es)
OA (1) OA12175A (es)
RU (1) RU2232572C2 (es)
UA (1) UA76097C2 (es)
WO (1) WO2002047661A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
ES2528631T3 (es) 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
JP4456177B2 (ja) 2007-09-04 2010-04-28 明治製菓株式会社 注射剤、注射液および注射用キット製剤
EP2243477A1 (de) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
JP2011225514A (ja) * 2009-10-30 2011-11-10 Kowa Co ロキソプロフェン又はその塩含有の医薬組成物
EP2926832A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen for topical use
EP2926810A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
WO2015165847A1 (en) 2014-04-29 2015-11-05 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations of loxoprofen
EP3160507A1 (en) 2014-06-30 2017-05-03 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and gamma-aminobutiric acid receptor agonist combinations
EP3197434A1 (en) 2014-09-24 2017-08-02 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
JPH0747535B2 (ja) * 1985-11-26 1995-05-24 日東電工株式会社 消炎鎮痛用貼付剤
JPH10120560A (ja) * 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy

Also Published As

Publication number Publication date
KR20020046407A (ko) 2002-06-21
RU2232572C2 (ru) 2004-07-20
JP2004515526A (ja) 2004-05-27
UA76097C2 (en) 2006-07-17
AP1530A (en) 2006-01-04
OA12175A (en) 2006-05-09
AP2002002594A0 (en) 2002-09-30
CN1400892A (zh) 2003-03-05
AU2002222750A1 (en) 2002-06-24
CN1278672C (zh) 2006-10-11
MXPA02007788A (es) 2002-10-17
KR100405161B1 (ko) 2003-11-12
BR0108313A (pt) 2003-03-11
WO2002047661A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
HN2001000224A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
MX2009010289A (es) Composiciones para administracion nasal.
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
AR059357A1 (es) Formulaciones farmaceuticas
MX9307555A (es) Derivados de paclitaxel y formulaciones farmaceuticas que los contienen.
CO6331425A2 (es) Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
CO5580767A2 (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
AR059359A1 (es) Formulaciones farmaceuticas que contienen pleconaril
AR043423A1 (es) Sistema de liberacion controlada
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
NO20081038L (no) Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
AR033596A1 (es) Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno
GT200600163A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
BRPI0507897B8 (pt) formulação de droga sólida
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
ES2150404T1 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
ECSP109871A (es) Soluciones farmacéuticas orales que contienen telbivudina
NO20064808L (no) Orale matrixformuleringer med licarbazepin

Legal Events

Date Code Title Description
FB Suspension of granting procedure